Strategic Global Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Strategic Global Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $3.49 Million - $4.7 Million	-6,367 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $184,487 - $216,513	310 Added 5.12%	6,367 $4.45 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $414,131 - $511,279	762 Added 14.39%	6,057 $3.83 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $724,999 - $860,052	1,263 Added 31.32%	5,295 $3.2 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $218,433 - $258,045	-462 Reduced 10.28%	4,032 $2.25 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $1.2 Million - $1.47 Million	2,678 Added 147.47%	4,494 $2.13 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $11,957 - $15,199	-25 Reduced 1.36%	1,816 $877,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $1 Million - $1.21 Million	1,841 New	1,841 $1.03 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Global Advisors, LLC with notifications on news.